GoodRx Holdings
GDRX
199 hedge funds and large institutions have $5.11B invested in GoodRx Holdings in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 53 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 55
1% less capital invested
Capital invested by funds: $5.14B → $5.11B (-$35.9M)
3% less funds holding
Funds holding: 205 → 199 (-6)
3.45% less ownership
Funds ownership: 207.37% → 203.91% (-3.5%)
11% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 53
24% less call options, than puts
Call options by funds: $96.6M | Put options by funds: $127M
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AM
Atreides Management
Boston,
Massachusetts
|
+$127M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.7M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
+$65.8M |
| 4 |
Goldman Sachs
New York
|
+$42.1M |
| 5 |
Teacher Retirement System of Texas
Austin,
Texas
|
+$39.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$53.9M |
| 2 |
FCIM
Fairview Capital Investment Management
Greenbrae,
California
|
-$46.6M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$26.7M |
| 4 |
BlackRock
New York
|
-$19.6M |
| 5 |
Jane Street
New York
|
-$15.8M |
GDRX Hedge Fund Activity: Q2 2021 in Review
199 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2021, worth a combined $5.11B — down 0.7% from $5.14B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of GDRX and 47 opened new positions — a net loss of 6 holders — while 55 trimmed existing stakes and 59 added.
The largest buyer was Atreides Management, opening a new position worth an estimated $127M. The largest seller was Invesco, cutting an estimated $53.9M.
- 199 institutional investors held GoodRx Holdings (GDRX) as of Q2 2021, down from 205 in Q1 2021.
- Funds reported $5.11B of GoodRx Holdings stock for Q2 2021, down 0.7% quarter-over-quarter.
- 47 funds opened new GoodRx Holdings positions in Q2 2021 and 53 closed out, a net change of -6 holders.
- The largest GoodRx Holdings buyer in Q2 2021 was Atreides Management, an estimated $127M added.
- The largest GoodRx Holdings seller in Q2 2021 was Invesco, an estimated $53.9M sold.
Based on aggregated 13F filings for Q2 2021.